What about hs-CRP? Isn't that important for CAD? Eh...

Well... first measure it a couple times because you may have just had a little cold illness when you measured hs-CRP at jacked it up.

Then...

Consider logically that hs-CRP can’t mechanically itself cause an occlusion. 

The data suggest that hs-CRP is capturing a different component of cardiovascular risk than ApoB. It is not simply another measure of cholesterol exposure. It appears to reflect the inflammatory environment that makes vascular disease more likely and plaques more dangerous.

For MI and stroke, the role of hs-CRP is thought to involve several mechanisms:

1. Plaque inflammation and instability (especially MI)

Atherosclerosis is not just a cholesterol-storage problem; it is an inflammatory disease.

ApoB containing particles enter the arterial wall → become retained/modified → immune cells respond → inflammatory signaling increases.

Inflammatory activity can:

• recruit macrophages (WBC elevation)

• increase cytokines (IL-6, IL-1β, TNF pathways)

• promote matrix degradation

• weaken the fibrous cap over plaques

A vulnerable plaque is more likely to rupture → clot formation → myocardial infarction.

So hs-CRP may be acting as a marker of:

“How inflamed and biologically active is the vascular system?”

2. Endothelial dysfunction

Elevated hs-CRP correlates with impaired endothelial function.

The endothelium normally:

• produces nitric oxide

• regulates vascular tone

• prevents inappropriate clotting

Inflammation can reduce nitric oxide availability → more:

• vasoconstriction

• platelet activation

• leukocyte adhesion

This creates a vascular environment more prone to ischemic events.

3. Thrombosis risk

After plaque disruption, the body’s clotting response determines whether a clinical event occurs.

Inflammatory states can promote:

• increased tissue factor expression

• platelet activation

• impaired fibrinolysis

This matters because many heart attacks and strokes occur when a clot forms on a plaque.

4. Stroke: inflammation + vascular injury

For ischemic stroke, hs-CRP is associated with higher risk through:

• accelerated atherosclerosis in carotid/cerebral arteries

• endothelial dysfunction

• increased thrombogenic tendency

• small-vessel disease processes

This is why prospective studies found hs-CRP predicts stroke risk even after accounting for traditional risk factors.

The key distinction:

ApoB answers:

“How many atherogenic particles are entering the artery?”

hs-CRP answers:

“How much inflammatory activity is occurring around the vessel wall?”

They interact:

ApoB particles → plaque formation → immune activation → hs-CRP elevation → plaque instability

But hs-CRP can also be elevated from other inflammatory/metabolic states, so it is not a pure plaque marker.

A useful clinical analogy:

• ApoB = fuel supply for the fire

• hs-CRP = how much smoke/fire activity is present

Both matter, but they measure different parts of the process. The strongest causal evidence for atherosclerosis initiation remains with ApoB-containing lipoproteins, while hs-CRP identifies a population with higher residual inflammatory risk.